Cellanome, Inc. — Form D/A

Cellanome, Inc. of Foster City, CA, a company, filed a Form D amendment with the SEC on 2023-03-21. The offering totals $40.7M, of which $40.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Kazutaka OhnoExecutive OfficerPalo Alto, CA
Mehdi KhodadadExecutive OfficerLos Angeles, CA
Mehdi KhodadadRelated PersonLos Angeles, CA
Mostafa RonaghiDirectorFoster City, CA
Mostafa RonaghiRelated PersonFoster City, CA
Rowan ChapmanDirectorMenlo Park, CA
Rowan ChapmanRelated PersonMenlo Park, CA
Ali AgahDirectorPalo Alto, CA
Ali AgahExecutive OfficerPalo Alto, CA
Tarun KhuranaExecutive OfficerPalo Alto, CA
Sue McGrathExecutive OfficerPalo Alto, CA
Jay FlatleyDirectorCarlsbad, CA
Jay FlatleyRelated PersonCarlsbad, CA
Omead OstadanDirectorFoster City, CA
Omead OstadanExecutive OfficerFoster City, CA
Omead OstadanPromoterFoster City, CA
Omead OstadanRelated PersonFoster City, CA
Sandesh PatnamRelated PersonFoster City, CA
Kazutaka Kumar OhnoExecutive OfficerRedwood City, CA
Mostafa Kumar RonaghiDirectorRedwood City, CA
Tarun Kumar KhuranaDirectorRedwood City, CA
Tarun Kumar KhuranaExecutive OfficerRedwood City, CA
Omead Kumar OstadanDirectorRedwood City, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2026-06-22D$75.9M$75.9M
2024-01-29D$150.0M$150.0M
2022-08-05D$30.0M$30.0M
2021-12-06D$21.0M$21.0M
2021-10-05D$2.0M$2.0M

More